Melanie Laporte

Montreal, QC H2X0A9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Enhanced detection of antigen-specific T cells by a multiplexed AIM assay.

Enhanced detection of antigen-specific T cells by a multiplexed AIM assay.

Journal: Cell reports methods

Published: July 20, 2023

An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.

An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.

Journal: iScience

Published: August 08, 2022

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile.

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile.

Journal: Cell reports. Medicine

Published: August 08, 2022

Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".

Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".

Journal: Journal of virology

Published: June 06, 2022

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.

Journal: Journal of virology

Published: March 28, 2022

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.

Journal: bioRxiv : the preprint server for biology

Published: January 04, 2022

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.

Journal: Cell reports

Published: January 04, 2022

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107.

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107.

Journal: mBio

Published: September 30, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026